Intelligence Β· Clinical Pipeline

ALMIRALL S.P.A Pipeline

All ClinicalTrials.gov programs at ALMIRALL S.P.A β€” phase, modality, and trial IDs.

Programs
11

Quick answer

ALMIRALL S.P.A has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Ebglyss 250 mg solution for injection in pre-filled syringe, Placebo, Ebglyss 250 mg solution for injection in pre-filled pen

    Almirall, S.A.

    Atopic Dermatitis

    phase 3 small molecule active

    1 trial
  2. Placebo, Ebglyss 250 mg solution for injection in pre-filled syringe

    Almirall, S.A.

    Nummular Dermatitis

    phase 3 small molecule active

    1 trial
  3. TIRBANIBULIN, Placebo of the new presentation of 350 mg/sachet drug product (hereafter referred as vehicle) is a smooth, creamy white to off-white ointment free from foreign particles, packed intact and properly sealed containing the same qualitative composition as the active product but without the active substance. The vehicle will be provided in a single-use packets to contain 350 mg of drug product., Klisyri 10 mg/g ointment

    Almirall, S.A.

    Actinic Keratosis on the Face or Scalp

    phase 3 small molecule active

    1 trial
  4. LAD328, SODIUM CHLORIDE

    Almirall, S.A.

    moderate-to-severe hidradenitis suppurativa

    phase 2 small molecule active

    1 trial
  5. Placebo for LAD603, LAD603

    Almirall, S.A.

    Alopecia areata

    phase 2 small molecule active

    1 trial
  6. SODIUM CHLORIDE, ADALIMUMAB, LAD191, LAD191 placebo

    Almirall, S.A.

    Moderate-to-severe hidradenitis suppurativa

    phase 2 small molecule active

    1 trial
  7. A study on the safety, tolerability, and effectiveness of the new drug LAD106 in healthy volunteers.

    Almirall, S.A.

    Inflammatory diseases

    phase 1 other active

    1 trial
  8. Almax Forte 1,5 g suspensiΓ³n oral

    Almirall, S.A.

    heartburn and or reflux

    approved small molecule active

    1 trial
  9. Klisyri 10 mg/g ointment, Solaraze 30 mg/g Gel

    Almirall, S.A.

    Actinic Keratosis

    approved small molecule active

    1 trial
  10. Pidotimod

    Almirall, S.A.

    Recurrent Respiratory Tract Infections

    approved small molecule completed

    1 trial
  11. Toujeo

    Almirall, S.A.

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does ALMIRALL S.P.A have?

11 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs